These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34527553)

  • 1. LRP6 as a biomarker of poor prognosis of breast cancer.
    Zhang Y; Shu C; Maimaiti Y; Wang S; Lu C; Zhou J
    Gland Surg; 2021 Aug; 10(8):2414-2427. PubMed ID: 34527553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.
    Kuerbanjiang A; Maimaituerxun M; Zhang Y; Li Y; Cui G; Abuduhabaier A; Aierken A; Miranbieke B; Anzaer M; Maimaiti Y
    BMC Gastroenterol; 2021 Feb; 21(1):86. PubMed ID: 33622273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
    Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
    J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
    Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
    Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival.
    Yang Y; Hong Q; Shi P; Liu Z; Luo J; Shao Z
    Breast Cancer Res; 2013 Jun; 15(3):R50. PubMed ID: 23786877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer.
    Fang Z; Shen HY; Xu Q; Zhou HL; Li L; Yang SY; Zhu Z; Tang JH
    Front Oncol; 2022; 12():1030571. PubMed ID: 36457503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.
    Wang YQ; Zhang QY; Weng WW; Wu Y; Yang YS; Shen C; Chen XC; Wang L; Liu KJ; Xu MD; Sheng WQ
    Int J Biol Sci; 2016; 12(5):545-57. PubMed ID: 27019636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP6 is involved in the proliferation, migration and invasion of trophoblast cells via miR‑346.
    Zhang L; Li H; Li M; Zhang W; Yang Z; Zhang S
    Int J Mol Med; 2020 Jul; 46(1):211-223. PubMed ID: 32319541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
    Liu H; Zhao YR; Chen B; Ge Z; Huang JS
    Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
    [No Abstract]   [Full Text] [Related]  

  • 18. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
    Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
    Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA‑629‑5p in colorectal cancer and prevention of the malignant phenotype by direct targeting of low‑density lipoprotein receptor‑related protein 6.
    Yan G; Li C; Zhao Y; Yue M; Wang L
    Int J Mol Med; 2019 Sep; 44(3):1139-1150. PubMed ID: 31257454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
    Ni J; Peng Y; Yang FL; Xi X; Huang XW; He C
    Onco Targets Ther; 2018; 11():3303-3312. PubMed ID: 29892197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.